Golda CF, 60 mg 30 pcs.

Oral hypoglycemic agent of the sulfonylurea group II generation

Indications

– Diabetes mellitus type 2 with insufficient effectiveness of diet therapy, physical activity and weight reduction.

– Prevention of complications of diabetes: reducing the risk of microvascular (nephropathy, retinopathy) and macrovascular complications (myocardial infarction, stroke) in patients with type 2 diabetes by intensive glycemic control.

Active ingredient

Composition

1 tablet contains:

Active substance:

gliclazide 60 mg

Ancillary substances:

Lactose monohydrate 94.0 mg;

Hypromellose 140.0 mg;

Sodium carboxymethyl starch type C 10.0 mg/20.0 mg;

magnesium stearate 4.0 mg;

colloidal silicon dioxide 2.0 mg.

How to take, the dosage

The drug is indicated for the treatment of adults only.

The recommended dose of gliclazide should be taken orally, once daily, preferably during breakfast.

The daily dose may range from 30 mg to 120 mg at one time.

It is recommended that the tablet be swallowed whole, without chewing or crushing.

If one or more doses of gliklazide are missed, the higher dose should be taken the next day.

As with other hypoglycemic drugs, the dose of the drug must be adjusted individually in each case, depending on the blood glucose concentration and HbAlc index.

Contraindications

– hypersensitivity to gliclazide, other sulfonylurea derivatives, sulfonamides or excipients included in the drug;

– type 1 diabetes mellitus;

– diabetic ketoacidosis, diabetic precoma, diabetic coma;

– severe renal or hepatic impairment (insulin is recommended in these cases);

– taking miconazole (see “Interaction with other medicinal products

– taking myconazole (see section “Interaction with other medicinal products”);

– pregnancy and breastfeeding (see section “Use during pregnancy and breastfeeding”);

– age under 18 years.

Due to the fact that the drug contains lactose, gliclazide is not recommended for patients with congenital lactose intolerance, galactosemia, glucose-galactose malabsorption.

The use in combination with phenylbutazone or danazol is not recommended.

Side effects

Given experience with gliclazide and other sulfonylurea derivatives, the following side effects should be kept in mind.

Hypoglycemia

Like other drugs of the sulfonylurea group, gliclazide may cause hypoglycemia if meals are not taken regularly and especially if meals are missed.

Other side effects:

gastrointestinal tract,

skin and subcutaneous tissue,

circulatory and lymphatic system,

/p>

Hepatic and biliary tract disorders,

visual side effects,

sulphonylurea derivatives side effects.

Similarities